Tag Archives: Alexion Pharmaceuticals

Analysts’ View: Golar LNG Partners (GMLP), Alexion Pharmaceuticals (ALXN), Fairmount Santrol (FMSA)

Brokerage Firm Stifel upgraded Golar LNG Partners LP (NASDAQ:GMLP)  shares from Hold to Buy rating while increasing their price target from $23 to $25.

Golar LNG Partners LP engages in the logistics solutions. Its activities include owning, trading, and operation of floating storage and regasification units (FSRU) and liquefied natural gas ( LNG) marine transportation.


Investment Analysts at Robert W. Baird upgraded Alexion Pharmaceuticals Inc. (NASDAQ:ALXN) shares from Neutral to Outperform rating with a price target of $150.

Alexion Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on serving patients with devastating and ultra-rare disorders through the development and commercialization of life-transforming therapeutic products.


Fairmount Santrol Holdings Inc. (NYSE:FMSA) shares were upgraded by analysts at Guggenheim from Neutral to Buy rating.

Fairmount Santrol Holdings, Inc. engages in the provision and supply of proppants and sand products.


Disclaimer: The disclaimer is to be read and fully understood before using our site, or joining our email list. CRWE.Info is not a registered investment adviser. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Investors should always conduct their own due diligence with any potential investment, with independent research and other professional advice. Read full disclaimer at http://www.crwe.info/disclaimer/